Jorge Alvarez Selected Research

Therapeutics

10/2019

High rates of early HCV reinfection after DAA treatment in people with recent drug use attended at mobile harm reduction units.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jorge Alvarez Research Topics

Disease

1	Disease Progression 12/2021
1	COVID-19 12/2021
1	Reinfection 10/2019
1	Transthyretin-Related Hereditary Amyloidosis 01/2019
1	Hypertension (High Blood Pressure) 08/2011
1	Dyspnea (Shortness of Breath) 01/2011
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2006
1	Hypersensitivity (Allergy) 01/2006
1	Drug-Related Side Effects and Adverse Reactions 01/2006

Drug/Important Bio-Agent (IBA)

2	Pharmaceutical PreparationsIBA 10/2019 - 01/2006
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2011
1	Oxygen (Dioxygen)IBA 01/2011
1	AdiponectinIBA 03/2006
1	Hormones (Hormone)IBA 03/2006
1	Clopidogrel (Plavix)FDA Link 01/2006
1	Sirolimus (Rapamycin)FDA Link 01/2006
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2006

Therapy/Procedure

1	Renal Dialysis (Hemodialysis) 12/2021
1	Therapeutics 10/2019
1	Liver Transplantation 01/2019
1	Drug-Eluting Stents 01/2006
1	Stents 01/2006